These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17196374)

  • 21. Anxiolytic-like effects of sinapic acid in mice.
    Yoon BH; Jung JW; Lee JJ; Cho YW; Jang CG; Jin C; Oh TH; Ryu JH
    Life Sci; 2007 Jun; 81(3):234-40. PubMed ID: 17570441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The four-plates test: anxiolytic or analgesic paradigm?
    Ripoll N; Hascoët M; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):873-80. PubMed ID: 16644084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors triggering abolishment of benzodiazepines effects in the Four-Plate Test--retest in mice.
    Petit-Demoulière B; Hascoët M; Bourin M
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):41-7. PubMed ID: 17544259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice.
    Girish C; Raj V; Arya J; Balakrishnan S
    Eur J Pharmacol; 2013 Jun; 710(1-3):49-58. PubMed ID: 23603526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior.
    Partyka A; Kłodzińska A; Szewczyk B; Wierońska JM; Chojnacka-Wójcik E; Librowski T; Filipek B; Nowak G; Pilc A
    Pharmacol Rep; 2007; 59(6):757-62. PubMed ID: 18195467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
    J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cholecystokinin tetrapeptide (CCK(4)) and of anxiolytic drugs on GABA outflow from the cerebral cortex of freely moving rats.
    Siniscalchi A; Rodi D; Cavallini S; Marino S; Ferraro L; Beani L; Bianchi C
    Neurochem Int; 2003 Jan; 42(1):87-92. PubMed ID: 12441172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytic effects of valproate and diazepam in mice are differentially sensitive to picrotoxin antagonism.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 2001 Jan; 68(1):23-32. PubMed ID: 11274704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze.
    da Silva ES; Poltronieri SC; Nascimento JO; Zangrossi H; Viana MB
    Behav Brain Res; 2011 Jan; 216(2):692-8. PubMed ID: 20883726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    Su YA; Si TM; Zhou DF; Guo CM; Wang XD; Yang Y; Shu L; Liang JH
    Eur J Pharmacol; 2007 Jun; 564(1-3):123-30. PubMed ID: 17395179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABAA/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa.
    Sollozo-Dupont I; Estrada-Camarena E; Carro-Juárez M; López-Rubalcava C
    J Ethnopharmacol; 2015 Mar; 162():278-86. PubMed ID: 25582489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats.
    Zarrindast MR; Solati J; Oryan S; Parivar K
    Pharmacology; 2008; 82(4):276-84. PubMed ID: 18849647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice.
    Wierońska JM; Stachowicz K; Brański P; Pałucha-Poniewiera A; Pilc A
    Neuropharmacology; 2012 Jan; 62(1):322-31. PubMed ID: 21855555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The aqueous crude extract of Montanoa frutescens produces anxiolytic-like effects similarly to diazepam in Wistar rats: involvement of GABAA receptor.
    Carro-Juárez M; Rodríguez-Landa JF; Rodríguez-Peña Mde L; Rovirosa-Hernández Mde J; García-Orduña F
    J Ethnopharmacol; 2012 Sep; 143(2):592-8. PubMed ID: 22885072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of 5-HT1A and GABAA receptors in the anxiolytic-like effects of Cinnamomum cassia in mice.
    Yu HS; Lee SY; Jang CG
    Pharmacol Biochem Behav; 2007 May; 87(1):164-70. PubMed ID: 17512974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-Hydroxy-2'-methoxy-6-methylflavone: a potent anxiolytic with a unique selectivity profile at GABA(A) receptor subtypes.
    Karim N; Gavande N; Wellendorph P; Johnston GA; Hanrahan JR; Chebib M
    Biochem Pharmacol; 2011 Dec; 82(12):1971-83. PubMed ID: 21924247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice.
    Matsumoto D; Ushio S; Wada Y; Noda Y; Esumi S; Izushi Y; Kitamura Y; Sendo T
    Eur J Pharmacol; 2021 Aug; 904():174195. PubMed ID: 34004209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.